We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Medtronic

Medtronic offers medical products and therapies for the treatment of cardiac and vascular diseases, diabetes, and neu... read more Featured Products: More products

Download Mobile App




Endoscopic Ablation System Eradicates Barrett’s Esophagus

By Theresa Herman
Posted on 02 May 2016
A novel radio frequency ablation (RFA) catheter simplifies circumferential ablation of Barrett’s esophagus (BE), as well as reducing procedure time by up to 20%.

The Barrx 360 Express RFA balloon catheter uses a proprietary bipolar electrode array set in a soft, compliant balloon material to provide a 360-degree, three-centimeter long ablation zone that delivers precise circumferential RFA energy to the targeted BE tissue area. More...
The procedure involves several steps: first, a soft sizing balloon is introduced to measure the diameter of the esophagus. The Barrx 360 RFA is then introduced over a guidewire, and the ablative energy is delivered, with the catheter moved distally to treat all targeted tissue. Focal catheters can be used for residual disease touch-up.

Components of the system include a proprietary RFA energy generator that automatically inflates to the appropriate size, based on the patient’s esophagus; sets the ablation parameters; and supplies energy to the soft sizing balloon and the RFA balloon catheter. The coagulum is removed from the ablation zone with a cleaning cap mounted on the endoscope. The Barrx 360 Express RFA is a product of Medtronic (Dublin, Ireland), and is available in five sizes, ranging from 18-31 mm.

“The biggest advantage of the Barrx 360 Express catheter is that it’s easier to use because of the larger, longer, and adjustable balloon size,” said Anthony Infantolino, MD, of Thomas Jefferson University Hospital (Philadelphia, PA, USA). “These new features provide for a reduction in surgery time and the number of catheters required during RFA procedures, allowing me to concentrate on increasing the quality of the procedure.”

BE refers to an abnormal change (metaplasia) in the cells of the lower portion of the esophagus, when the normal squamous epithelium lining of the esophagus is replaced by goblet cells, which are usually found lower in the GI tract. The medical significance of Barrett esophagus is its strong association with esophageal adenocarcinoma, a particularly lethal form of cancer.

Related Links:
Medtronic
Thomas Jefferson University Hospital

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
12-Channel ECG
CM1200B
Fetal Monitor
BT-380
Syringe Pump
SP50 Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The investigational niia signature wearable patch combines continuous glucose monitoring, insulin delivery, and automated glucose control in a single system. (photo courtesy of PharmaSens)

Wearable Patch Prototype Advances Toward Integrated Automated Insulin Delivery

Diabetes management requires individualized care, reliable glucose and ketone monitoring, and timely intervention. For automated insulin delivery, a key challenge is maintaining accurate glucose measurements... Read more

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Medical Imaging

view channel
Image: Visual Abstract (Andrea Farolfi et al., Journal of Nuclear Medicine, 2026. DOI: 10.2967/jnumed.126.272108)

PSMA PET/CT-Guided Biopsy Improves Detection of Significant Prostate Cancer After Nondiagnostic MRI

Prostate cancer can be difficult to detect when magnetic resonance imaging (MRI) findings are negative or inconclusive. Men with persistent clinical risk factors may still require biopsy, yet standard... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: WHX returns to Dubai Exhibition Centre, Expo City, and Dubai World Trade Centre from 5–28 January 2027 (Photo courtesy of World Health Expo)

World Health Expo to Showcase Trillion-Dollar Growth Across Pharma, Biotech, Longevity and Wellness at 2027 Edition

World Health Expo (WHX) expands with the new Pharma, Biotech, Longevity and Wellness industry sectors More than 235,000 professional visits, over 4,200 exhibitors and representatives from over... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.